- Net asset value per share for Aker in Q4 stood at NOK 783.
- Aker successfully executed several major projects during this period.
- Significant transactions were completed, leading to substantial dividends.
- More than NOK 32 billion in dividends were distributed by Aker’s portfolio companies.
- Aker distributed these dividends to themselves and other shareholders.
- There were 7 buy recommendations, 1 hold recommendation, and no sell recommendations for Aker.
A look at Aker ASA Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 2 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, Aker ASA is poised for a positive long-term outlook. Aker excels in providing strong dividends, with a top score of 5 in this area, indicating a reliable income stream for investors. Additionally, Aker’s value is rated highly at 4, showcasing the company’s solid fundamentals and potential for growth. Although growth and momentum scores are more moderate at 2 and 3 respectively, Aker’s resilience score of 3 suggests a stable foundation that can weather market fluctuations.
Aker ASA, an industrial investment company with a focus on oil and gas, seafood, and marine biotechnology sectors, strategically leverages its expertise in active ownership. With significant holdings in various listed companies across key industries, Aker’s global operations position it as a diversified and robust investment option. The company’s high dividend score of 5 underscores its commitment to providing returns to shareholders, while its strong value score of 4 reflects a sound financial footing for sustained growth in the long term.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
